Wednesday, May 24, 2017 11:20:51 AM
LOS ANGELES, CA / ACCESSWIRE / May 15, 2017 / Omni-Lite Industries Canada Inc. (TSX-V: OML and OTCQX: OLNCF), a world recognized aerospace and military contractor with the core mission of utilizing advanced material science for mission critical applications, today announced that it will be presenting at the 7th annual LD Micro Invitational on Tuesday, June 6th at 11:30 AM PDT / 2:30 PM EDT. David Grant, Founder and CEO of Omni-Lite, will be giving the presentation and meeting with investors.
The Company's Investor and Corporate Presentations can be found on the Omni-Lite website at www.omni-lite.com.
"This year, not only do we have a record number of companies making their LD Micro debuts, but a record number of companies presenting for the first time in their company's history" stated Chris Lahiji, President of LD Micro. "LD has established itself as the one venue that brings the most influential players from all segments of the market under one roof."
The conference will be held at the Luxe Sunset Bel Air Hotel and will feature 180 companies in the small / micro-cap space.
View Omni-Lite's profile here: http://www.ldmicro.com/profile/OLNCF
Profiles powered by LD Micro - News Compliments of Accesswire
About Omni-Lite Industries Canada Inc.
Omni-Lite Industries Canada Inc. is a world recognized research and development Company with the core mission of utilizing material science for mission critical applications. The Company's specialized, precision components are produced utilizing computer-controlled hot and cold forging systems that are networked to provide an optimal environment for engineering enhancements, leading to maximum production efficiencies. These capabilities provide financial benefits such as high industry gross and net margins, and significant cash flow and EBITDA ratios, which allow the Company to execute an ambitious growth strategy. One of the Company's key growth catalysts is the recent development of a specialized process for the production of aerospace titanium components.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM